First-line in all diabetics |
---|
|
Preferred second-line in diabetics with CVD (or high risk for CVD), heart failure, or chronic kidney disease |
SGLT2 inhibitors
|
Preferred second-line in diabetics with CVD (or high risk for CVD) |
GLP-1 analogs
|
Other treatments |
Sulfonylureas (e.g. glipizide, glyburide)
|
Glitazones (Actos, Avandia)
|
Insulin therapy
|
DPP-4 inhibitors
|
Other therapies (not generally recommended)
|
Insulin | Reduced cost programs | Free programs |
---|---|---|
Basaglar, Humalog, Humulin N, Humulin R, Humalog Mix 50/50, Humalog Mix 75/25 |
Lilly Insulin Value Program
|
Lilly Cares program
|
Lantus, Toujeo, Admelog, Apidra |
Sanofi Insulin Value Savings Program
|
Sanofi Patient Connection
|
Levemir, Tresiba, Novolog, Fiasp Novolin N, Novolin R, Novolin 70/30, Novolog Mix 70/30 |
My$99Insulin Program
|
NovoCare Patient Assistance Program
|
NPH and Regular |
Walmart
|
NovoCare Patient Assistance Program
Lilly Cares program
|
SGLT2 inhibitor Patient Assistance Program Information |
---|
Canagliflozin (Invokana®, Invokamet®, Invokamet® XR)
|
Dapagliflozin (Farxiga®, Qtern®, Xigduo XR®)
|
Empagliflozin (Jardiance®, Glyxambi®,Synjardy®, Synjardy® XR)
|
Ertugliflozin (Steglatro®)
|
GLP-1 analog Patient Assistance Program Information |
---|
Albiglutide (Tanzeum™)
|
Dulaglutide (Trulicity™)
|
Exenatide (Bydureon®, Byetta®)
|
Liraglutide (Victoza®)
|
Liraglutide (Saxenda®)
|
Lixisenatide (Adlyxin®)
|
Semaglutide (Ozempic®)
|
Semaglutide (Rybelsus®)
|
DPP-4 inhibitor Patient Assistance Program Information |
---|
Alogliptin (Nesina®, Oseni®, Kazano®)
|
Linagliptin (Tradjenta®, Glyxambi®,Jentadueto®,Jentadueto® XR)
|
Saxagliptin (Onglyza®, Kombiglyze® XR, Qtern®)
|
Sitagliptin (Januvia®, Janumet®, Janumet® XR)
|